Reprogramming Turns Cancer Cells into Immune Allies

Abstract: A novel immune-oncology strategy that involves reprogramming cancer cells into functional dendritic cells directly in the body elicits strong immune responses and complete tumor regression in mice. The approach, which uses adenoviral vectors to deliver transcription factors into tumors, is expected to enter human testing in the next few years.